Connor, Clark & Lunn Investment Management (CC&L)’s CareDx CDNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21.1M | Buy |
1,082,308
+78,728
| +8% | +$1.54M | 0.07% | 237 |
|
2025
Q1 | $17.8M | Buy |
1,003,580
+128,383
| +15% | +$2.28M | 0.08% | 215 |
|
2024
Q4 | $18.7M | Buy |
875,197
+178,304
| +26% | +$3.82M | 0.08% | 184 |
|
2024
Q3 | $21.8M | Buy |
696,893
+306,222
| +78% | +$9.56M | 0.11% | 158 |
|
2024
Q2 | $6.07M | Buy |
390,671
+128,926
| +49% | +$2M | 0.03% | 385 |
|
2024
Q1 | $2.77M | Buy |
261,745
+93,430
| +56% | +$989K | 0.01% | 584 |
|
2023
Q4 | $2.02M | Buy |
168,315
+29,761
| +21% | +$357K | 0.01% | 663 |
|
2023
Q3 | $970K | Sell |
138,554
-54,887
| -28% | -$384K | 0.01% | 832 |
|
2023
Q2 | $1.64M | Buy |
193,441
+4,755
| +3% | +$40.4K | 0.01% | 659 |
|
2023
Q1 | $1.72M | Buy |
188,686
+75,500
| +67% | +$690K | 0.01% | 585 |
|
2022
Q4 | $1.29M | Buy |
113,186
+26,521
| +31% | +$303K | 0.01% | 646 |
|
2022
Q3 | $1.48M | Buy |
86,665
+63,497
| +274% | +$1.08M | 0.01% | 567 |
|
2022
Q2 | $498K | Buy |
+23,168
| New | +$498K | ﹤0.01% | 778 |
|
2021
Q3 | – | Sell |
-32,322
| Closed | -$2.96M | – | 1063 |
|
2021
Q2 | $2.96M | Buy |
32,322
+7,449
| +30% | +$682K | 0.02% | 461 |
|
2021
Q1 | $1.69M | Buy |
24,873
+14,065
| +130% | +$958K | 0.01% | 599 |
|
2020
Q4 | $783K | Buy |
+10,808
| New | +$783K | ﹤0.01% | 667 |
|